EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Probiotics, prebiotics, and postbiotics in health and disease

Jing Ji, Weilin Jin, Shuang-Jiang Liu, Zuoyi Jiao, Xiangkai Li iD

MedComm · 2023-12 · 4 (6)

DOI: 10.1002/mco2.420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 04.11.2023. Verfasst von Jing Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Cell Activities and Stress Adaptations School of Life Sciences Lanzhou University Lanzhou Gansu China. Die Arbeit wurde bisher 390-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota and its homeostasis play a crucial role in human health. However, for some diseases related to the gut microbiota, current traditional medicines can only relieve symptoms, and it is difficult to solve the root causes or even cause side effects like disturbances in the gut microbiota. Increasing clinical studies and evidences have demonstrated that probiotics, prebiotics, and postbiotics can prevent and treat various diseases, but currently they can only be used as dietary supplements rather than medicines, which restricts the application of probiotics in the field of medicine. Here, this review analyzes the importance of gut microbiota in human health and the current problems of traditional medicines, and systematically summarizes the effectiveness and mechanisms of probiotics, prebiotics, and postbiotics in maintaining health and treating diseases based on animal models and clinical trials. And based on current research outcomes and development trends in this field, the challenges and prospects of their clinical application in maintaining health, alleviating and treating diseases are analyzed. It is hoped to promote the application of probiotics, prebiotics, and postbiotics in disease treatment and open up new frontiers in probiotic research.

Schlagwörter

Stichwörter der Autor:innen

clinical trialsgut microbiotapostbioticsprebioticsprobiotics

Autor:innen und Institutionen

  • MOE Key Laboratory of Cell Activities and Stress Adaptations School of Life Sciences Lanzhou University Lanzhou Gansu China.
  • Institute of Cancer Neuroscience Medical Frontier Innovation Research Center The First Hospital of Lanzhou University The First Clinical Medical College of Lanzhou University Lanzhou Gansu China.
  • State Key Laboratory of Microbial Resources Institute of Microbiology Chinese Academy of Sciences Beijing China.
  • Cuiying Biomedical Research Center The Second Hospital of Lanzhou University Lanzhou Gansu China.

ORCID-Profile: Xiangkai Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ji, J., Jin, W., Liu, S. J., Jiao, Z., & Li, X. (2023). Probiotics, prebiotics, and postbiotics in health and disease. MedComm, 4(6). https://doi.org/10.1002/mco2.420

Vancouver

Ji J, Jin W, Liu SJ, Jiao Z, Li X. Probiotics, prebiotics, and postbiotics in health and disease. MedComm. 2023;4(6). doi:10.1002/mco2.420

BibTeX
@article{Ji2023,
  author = {Ji, Jing and Jin, Weilin and Liu, Shuang-Jiang and Jiao, Zuoyi and Li, Xiangkai},
  title = {Probiotics, prebiotics, and postbiotics in health and disease},
  journal = {MedComm},
  year = {2023},
  volume = {4},
  number = {6},
  doi = {10.1002/mco2.420}
}
Kostenlos starten →